NCT07360002

The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 102 (estimated)
• Sponsor: Keda Lu · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if Shenqi Yishen Granules works to treat IgA Nephropathy in adults. It will also learn about the safety of Shenqi Yishen Granules. The main questions it aims to answer are: Does Shenqi Yishen Granules lower 24-hour urinary protein quantification of participants? What medical problems do participants have when taking Shenqi Yishen Granules? Researchers will compare Shenqi Yishen Granules to a placebo (a look-alike substance that contains no drug) to see if Shenqi Yishen Granules works to treat IgA Nephropathy.

Conditions

• IgA Nephropathy (IgAN)

Interventions

Type	Name	Description
DRUG	Shenqi Yishen Granules	A traditional Chinese medicine compound for the treatment of IgA nephropathy
DRUG	Placebo	a look-alike substance that contains no drug

Timeline

• Start date: 2026-01-01
• Primary completion: 2026-12-01
• Completion: 2026-12-01
• First posted: 2026-01-22
• Last updated: 2026-01-22